Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

October 9, 2018

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Acute Respiratory Viral Infections
Interventions
DRUG

Anaferon

Oral administration.

DRUG

Placebo

Oral administration.

Trial Locations (19)

117593

The Federal State Budgetary Healthcare Institution The Central Clinical Hospital of the Russian Academy of Sciences, Moscow

117997

Pirogov Russian National Research Medical University, Moscow

119121

"Federal State Institution Polyclinic No. 5 of the Administrative Department of the President of the Russian Federation", Moscow

142105

Podolskaya City Clinical Hospital No. 3, Podolsk

143408

Krasnogorsk city hospital №1, Krasnogorsk

143964

Central City Clinical Hospital of Reutov, Reutov

150000

Yaroslavl State Medical University, Yaroslavl

193312

"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 25", Saint Petersburg

194358

"St. Petersburg State Health Care Institution City Polyclinic №117", Saint Petersburg

195271

Road Clinical Hospital JSC Russian Railways, Saint Petersburg

196143

"LLC Research Center Eco-Security", Saint Petersburg

196211

"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 51", Saint Petersburg

196247

"St. Petersburg City State Hospital City Hospital No. 26", Saint Petersburg

197198

"St. Petersburg State Budgetary Institution of Health City Polyclinic №34", Saint Petersburg

214006

"Regional State Budgetary Healthcare Institution Clinical Hospital No.1", Smolensk

410028

Saratov City Clinical Hospital № 2 named after VI Razumovsky, Saratov

420012

Kazan State Medical University, Kazan'

454000

"Non-governmental health care institution Road Clinical Hospital at Chelyabinsk station JSC Russian Railways ", Chelyabinsk

656045

"Regional State Budgetary Healthcare Institution City Hospital No. 5, Barnaul", Barnaul

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT03707912 - Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections | Biotech Hunter | Biotech Hunter